Skip to content

Providing Novel Diagnostics & Therapeutics in Cancer and Neurological Diseases

Science & Technology

Investor Resources

Stock Information

Science & Technology

Investor Resources

Stock Information

OTC Markets:

XSNX 0.48 -0.02 -4.90%

OTC Markets: XSNX 0.48 -0.02 -4.90%

/

Uncategorized

Category: Uncategorized

XsunX, Inc. Changes Name to NovAccess Global Inc.

By ivst_adminIn UncategorizedPosted August 26, 2020

Search for:

Recent Posts

NovAccess Global, Inc. to Present at the Prestigious Society for Brain Mapping and Therapeutics 2021 World Congress
NovAccess Global, Inc. Announces Successful Completion of Pre-IND Meeting with FDA
NovAccess Global Readies for Development of Novel Immunotherapies for Brain Tumor Patients with pre-IND meeting scheduled with the FDA and Files Form 10-K for Fiscal 2020 and Form 10-Q for FQ1/FQ2, 2021
NovAccess Global Secures Worldwide Rights to Approved Patent
NovAccess Global Enhances Scientific Advisory Board with Distinguished Industry Experts and adds Chief Financial Officer

Recent Comments

Archives

July 2021
June 2021
November 2020
October 2020
September 2020
August 2020
September 2019
July 2019
December 2018
November 2018
August 2018
July 2018
March 2018

Categories

NovAccess Global Press Releases
Press Release
Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

©2021 NovAccess Global

(440) 688-0378

Terms & Privacy Policy

©2021 NovAccess Global

440.688.0378

Terms & Privacy Policy

©2020 NovAccess Global 440.644.1027 Terms & Privacy Policy

Forward Looking Statements

This website contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this website are forward-looking statements. These statements relate to future events or to the Company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company’s filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.